Forschungsprojekte
Ergebnisse pro Seite:
25
2017 - 2021
Polymer-mediated tumor immunotherapy by in situ activation of antigen-presenting cells- Dr. LutzNuhn,
- Univ.-Prof. Dr. HansjörgSchild,
- Univ.-Prof. Dr. StephanGrabbe
2017 - 2021
Development and testing of nanoparticles for inhibition of cAMP-mediated immunosuppression of malignant melanoma- Dr. MatthiasBarz,
- PD Dr. ChristianBecker,
- Univ.-Prof. Dr. TobiasBopp
2017 - 2021
Proteins on nanocarriers: from the stealth effect to targeted targeting in vivo SFB-1066/B11- Prof. Dr. VolkerMailänder,
- Univ.-Prof. Dr. StefanTenzer
2017 - 2021
Nanodimensionale polymere Therapeutika für Tumortherapie Teilprojekt SFB 1066/B6- Prof. Dr. KerstinSteinbrink
2017 - 2020
Modulation of allergen-induced lung and gut inflammation by nutritional wheat amylase trypsin inhibitors (ATIs), activators of the innate immune system- Univ.-Prof. Dr. Dr. DetlefSchuppan,
- PD Dr. IrisBellinghausen
2017 - 2021
SFB 1066 Nanodimensional polymer therapeutics for tumor therapy- Prof. Dr. StephanGrabbe,
- PD Dr. MatthiasBros,
- Prof. Dr. KerstinSteinbrink,
- Prof. Dr. AndreaTüttenberg,
- Prof. Dr. VolkerMailänder,
- PD Dr. ChristianBecker
2017 - 2021
Nanodismensionale polymere Therapeutika für die Tumortherapie und Makrophagen SFB 1066 B03- Prof. Dr. AndreaTüttenberg
2016 - 2019
Characterization of phenotype and function of ILC in cutaneous leishmaniasis | Priority Programme „Innate lymphoid cells“ (SPP1937)- Univ.-Prof. Dr. Esthervon Stebut-Borschitz